Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

ProQR Therapeutics (PRQR) Debt Ratio (2016 - 2025)

ProQR Therapeutics' Debt Ratio history spans 6 years, with the latest figure at 0.04 for Q4 2025.

  • On a quarterly basis, Debt Ratio rose 58.38% to 0.04 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.04, a 58.38% increase, with the full-year FY2025 number at 0.04, up 58.38% from a year prior.
  • Debt Ratio hit 0.04 in Q4 2025 for ProQR Therapeutics, up from 0.03 in the prior quarter.
  • Over the last five years, Debt Ratio for PRQR hit a ceiling of 0.21 in Q2 2022 and a floor of 0.0 in Q1 2021.
  • Historically, Debt Ratio has averaged 0.08 across 5 years, with a median of 0.04 in 2022.
  • Biggest five-year swings in Debt Ratio: soared 111938431.77% in 2022 and later tumbled 88.55% in 2023.
  • Tracing PRQR's Debt Ratio over 5 years: stood at 0.21 in 2021, then plummeted by 81.21% to 0.04 in 2022, then dropped by 21.24% to 0.03 in 2023, then decreased by 12.36% to 0.03 in 2024, then surged by 58.38% to 0.04 in 2025.
  • Business Quant data shows Debt Ratio for PRQR at 0.04 in Q4 2025, 0.03 in Q4 2024, and 0.03 in Q4 2023.